EXACT SCIENCES (EXK MU) stock market data APIs
€44.2839
-0.3(-0.7%)
as of September 18, 2025
Try our APIs with
free plan!
EXACT SCIENCES Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EXK.MU.
Prev. Close
44.2839
Open
43.984
High
44.2839
Low
43.984
52 wk Range
33.805-66.06
Market Cap
12 100 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EXACT SCIENCES data using free add-ons & libraries
Get EXACT SCIENCES Fundamental Data
EXACT SCIENCES Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXACT SCIENCES News
New
Healthmine and Exact Sciences Partner to Combine At-Home CRC Screening with Health Plan Incentives to Boost Preventive Care
DALLAS, September 17, 2025--(BUSINESS WIRE)--Healthmine, a leading member engagement and rewards platform for health plans, announced a strategic partnership with Exact Sciences, a global leader in ca...
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. While you may have an investing style you rely on...
Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs
Exact Sciences Corporation EXAS has launched the Cancerguard test, a new multi-cancer early detection (MCED) blood test now offered as a laboratory-developed test (LDT) in the United States. Cancergua...
Exact Sciences price target raised to $85 from $65 at Craig-Hallum
Craig-Hallum raised the firm’s price target on Exact Sciences (EXAS) to $85 from $65 and keeps a Buy rating on the shares. The firm would be a buyer of Exact Sciences. With the Freenome deal in plac...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
